Ghofrani, Hossein-Ardeschir

Riociguat for the treatment of pulmonary arterial hypertension

Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and Treatments

Cited by 1,346

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and Treatments

Cited by 660

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Gräf, S., Haimel, M., Bleda, M., Hadinnapola, C., Southgate, L., Li, W., Hodgson, J., Liu, B., Salmon, R. M., Southwood, M., et al. (2018) · Nature Communications

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and Treatments

Cited by 380

Prevalence of mental disorders and impact on quality of life in patients with pulmonary arterial hypertension.

Olsson, K. M., Meltendorf, T., Fuge, J., Kamp, J. C., Park, D.-H., Richter, M. J., Gall, H., Ghofrani, H. A., Ferrari, P., Schmiedel, R., et al. (2021) · Frontiers in Psychiatry

Pulmonary Hypertension Research and TreatmentsCardiac Health and Mental Health

Cited by 55